BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38461568)

  • 1. Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
    Bizzarri N; Fedele C; Teodorico E; Certelli C; Pedone Anchora L; Carbone V; Giannarelli D; Fagotti A; Zannoni GF; Valente M; Querleu D; Ferrandina G; Scambia G; Fanfani F
    Eur J Surg Oncol; 2024 Apr; 50(4):108250. PubMed ID: 38461568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Santoro A; Angelico G; Inzani F; Arciuolo D; Spadola S; Valente M; D'Alessandris N; Piermattei A; Fiorentino V; CIanfrini F; Bizzarri N; Pedone Anchora L; Fagotti A; Scambia G; Zannoni GF
    Int J Gynecol Cancer; 2020 Dec; 30(12):1871-1877. PubMed ID: 33127865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the one-step nucleic acid amplification method for rapid detection of lymph node metastases in endometrial cancer: prospective, multicenter, comparative study.
    La Fera E; Bizzarri N; Petrecca A; Monterossi G; Dinoi G; Zannoni GF; Restaino S; Palmieri E; Mariuzzi L; Peters I; Scambia G; Fanfani F
    Int J Gynecol Cancer; 2023 Jul; 33(7):1063-1069. PubMed ID: 37105584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carbon nanoparticle tracing of sentinel lymph nodes in diagnosis and treatment of cervical cancer and clinical value of lymph node ultrastaging detection].
    Lin X; He J; Lu J; Huang C; Liu N
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1896-1901. PubMed ID: 36651260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison.
    Fanfani F; Monterossi G; Di Meo ML; La Fera E; Dell'Orto F; Gioè A; Lamanna M; Ferrari D; De Ponti E; Perego P; Restaino S; Carlo R; Zannoni GF; Landoni F; Scambia G; Buda A
    Int J Gynecol Cancer; 2020 Mar; 30(3):372-377. PubMed ID: 31996396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients.
    Kosťun J; Pešta M; Sláma J; Slunéčko R; Vlasák P; Bouda J; Novotný Z; Topolčan O; Kučera R; Kulda V; Houfková K; Berezovskiy D; Bartáková A; Presl J
    J Surg Oncol; 2019 Mar; 119(3):361-369. PubMed ID: 30508294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-operative assessment of sentinel lymph node status by one-step nucleic acid amplification assay (OSNA) in early endometrial cancer: a prospective study.
    Monterossi G; Buca D; Dinoi G; La Fera E; Zannoni GF; Spadola S; Scambia G; Fanfani F
    Int J Gynecol Cancer; 2019 Jul; 29(6):1016-1020. PubMed ID: 31175137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
    Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
    Schiavone MB; Scelzo C; Straight C; Zhou Q; Alektiar KM; Makker V; Soslow RA; Iasonos A; Leitao MM; Abu-Rustum NR
    Ann Surg Oncol; 2017 Jul; 24(7):1965-1971. PubMed ID: 28258415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative evaluation of metastases in sentinel nodes through one-step nucleic acid amplification: Initial experience in a single institution.
    Pohlodek K; Feriancova M; Kotvanova K; Meciarova I
    Bratisl Lek Listy; 2023; 124(3):163-169. PubMed ID: 36598305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
    Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z
    Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel Lymph Node Mapping in Lung Cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell Lung Cancer.
    Romano G; Zirafa CC; Calabrò F; Alì G; Manca G; De Liperi A; Proietti A; Manfredini B; Di Stefano I; Marciano A; Davini F; Volterrani D; Melfi F
    Tomography; 2024 May; 10(5):761-772. PubMed ID: 38787018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis.
    Lee D; Kim YN; Cho SH; Yoon HS; Kim YT; Kim S; Kim SW
    J Gynecol Oncol; 2023 Nov; 34(6):e79. PubMed ID: 37477102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study.
    Togami S; Ushiwaka T; Kitazono I; Yanazume S; Kamio M; Tanimoto A; Kobayashi H
    J Gynecol Oncol; 2022 Mar; 33(2):e11. PubMed ID: 34910392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.